Consun Pharmaceutical Group Limited announced that Mr. WANG Shunlong, a non-executive Director, has retired by rotation at the annual general meeting of the company held on 31 May 2017 and has not offered himself for re-election as he would like to devote more time to develop his own business. Accordingly, Mr. Wang ceased to be a non-executive Director with effect from the conclusion of the AGM on 31 May 2017. Mr. Wang has confirmed that he has no disagreement with the Board and there is no matter that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited and/or the shareholders of the company. Change of composition of the audit committee. Mr. Wang has ceased to be a member of the audit committee of the company; and Mr. SU Yuanfu, an independent non-executive Director of the company, has been appointed as a member of the audit committee of the company, these are changes effective from May 31, 2017. Resignation of joint company secretary. The board hereby announced that, with effect from 31 May 2017, Mr. GAO Haien has resigned as the company's joint company secretary due to his commitments to the Group as the board secretary of the company and the legal representative of the company's certain major subsidiaries which require more of his dedication. Mr. Gao confirmed that he has no disagreement with the board and there is no matter relating to his resignation that needs to be brought to the attention of The Stock Exchange of Hong Kong Limited and/or the shareholders of the company. Immediately after the aforesaid resignation, Mr. YAU Chi Ming, the other joint company secretary of the company.